Outcome predictions for patients with metastatic prostate cancer Journal Article
| Authors: | Smaletz, O.; Scher, H. I. |
| Article Title: | Outcome predictions for patients with metastatic prostate cancer |
| Abstract: | Estimating prognosis with patients with metastatic disease is important for patient counseling, guiding treatment selection, and assessing treatment outcomes. For patients with noncastrate metastatic disease, androgen ablation is considered first-line therapy, with upward of 80% of patients showing clinical benefit. For these patients, information about duration of response to hormones and overall survival is important. Most patients eventually relapse, at which point the mortality from cancer greatly exceeds that from other causes. This article focuses on prognostic models for patients with progressive noncastrate and castrate metastatic prostate cancer. Copyright 2002, Elsevier Science (USA). All rights reserved. |
| Keywords: | survival; cancer survival; treatment outcome; survival rate; clinical trial; cytotoxic agent; doxorubicin; interferon; cancer combination chemotherapy; treatment planning; gemcitabine; metastasis; etoposide; vinblastine; cancer hormone therapy; prostate cancer; prostate-specific antigen; prostatic neoplasms; goserelin; leuprorelin; eflornithine; mitoxantrone; neoplasm metastasis; outcome and process assessment (health care); mitomycin c; diethylstilbestrol; antiandrogen; bicalutamide; flutamide; gonadorelin derivative; hydrocortisone; nilutamide; orchiectomy; antineoplastic agents, hormonal; isotretinoin; retinoic acid; leuprolide; patient counseling; suramin; megestrol acetate; trimetrexate; estramustine; edatrexate; gallium nitrate; rhenium 186; humans; prognosis; human; male; priority journal; article; buserelin |
| Journal Title: | Seminars in Urologic Oncology |
| Volume: | 20 |
| Issue: | 2 |
| ISSN: | 1081-0943 |
| Publisher: | W.B. Saunders Co. |
| Date Published: | 2002-05-01 |
| Start Page: | 155 |
| End Page: | 163 |
| Language: | English |
| PUBMED: | 12012302 |
| PROVIDER: | scopus |
| DOI: | 10.1053/suro.2002.32938 |
| DOI/URL: | |
| Notes: | Export Date: 11 February 2015 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work